TLP

Tri Locum Partners Portfolio holdings

AUM $330M
1-Year Return 35.44%
This Quarter Return
+17.97%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$215M
AUM Growth
-$23.8M
Cap. Flow
-$33.6M
Cap. Flow %
-15.62%
Top 10 Hldgs %
74.17%
Holding
41
New
12
Increased
7
Reduced
5
Closed
13

Top Buys

1
BAX icon
Baxter International
BAX
$25.1M
2
SGEN
Seagen Inc. Common Stock
SGEN
$16.4M
3
MRK icon
Merck
MRK
$13.7M
4
SKIN icon
The Beauty Health Co
SKIN
$13.1M
5
SRPT icon
Sarepta Therapeutics
SRPT
$12.5M

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
$37.3M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$15.9M
3
PTGX icon
Protagonist Therapeutics
PTGX
$15.3M
4
JNJ icon
Johnson & Johnson
JNJ
$14.1M
5
CI icon
Cigna
CI
$12M

Sector Composition

1 Healthcare 93.78%
2 Consumer Staples 6.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CI icon
26
Cigna
CI
$81.2B
– –
-50,699
Closed -$12M
CLDX icon
27
Celldex Therapeutics
CLDX
$1.51B
– –
-175,305
Closed -$5.86M
EOLS icon
28
Evolus
EOLS
$486M
– –
-496,826
Closed -$6.29M
FLGT icon
29
Fulgent Genetics
FLGT
$673M
– –
0
– –
HUM icon
30
Humana
HUM
$37.5B
– –
-11,305
Closed -$5.01M
JAZZ icon
31
Jazz Pharmaceuticals
JAZZ
$7.77B
– –
-89,370
Closed -$15.9M
JNJ icon
32
Johnson & Johnson
JNJ
$431B
– –
-85,596
Closed -$14.1M
MREO
33
Mereo BioPharma
MREO
$275M
– –
-1,253,729
Closed -$3.97M
MRNA icon
34
Moderna
MRNA
$9.45B
– –
-19,193
Closed -$4.51M
NVAX icon
35
Novavax
NVAX
$1.27B
– –
0
– –
PFE icon
36
Pfizer
PFE
$140B
– –
-202,692
Closed -$7.94M
PTGX icon
37
Protagonist Therapeutics
PTGX
$3.71B
– –
-341,650
Closed -$15.3M
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-150,783
Closed -$6.16M
ENDP
39
DELISTED
Endo International plc
ENDP
– –
0
– –
ALDX icon
40
Aldeyra Therapeutics
ALDX
$332M
– –
-818,025
Closed -$9.27M
TEVA icon
41
Teva Pharmaceuticals
TEVA
$21.2B
– –
0
– –
1
2